Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
La Rosa Abel De currently holds 16,800 shares of Virios Therapeutics, Inc. (VIRI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, La Rosa Abel De has been a net buyer of VIRI stock. They have purchased $23.6K and sold $0 worth of shares.
La Rosa Abel De's most recent insider trade was on Jun 16, 2026, when they sold 16,800 shares at $0.00 per share.
La Rosa Abel De serves as Executive at Virios Therapeutics, Inc. (VIRI). They have executed 3 insider transactions totaling $23.6K over their tenure at the company.
La Rosa Abel De holds the position of Executive at Virios Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 5 years and currently hold a stake valued at $0.
La Rosa Abel De has shown a buying trading pattern, with $23.6K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by La Rosa Abel De was on Jan 7, 2022, when they purchased $23.6K worth of VIRI shares. This transaction involved 4,000 shares at $5.90 per share.
La Rosa Abel De currently owns 16,800 shares of Virios Therapeutics, Inc. (VIRI), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of La Rosa Abel De's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. La Rosa Abel De has 3 Form 4 filings on record as an insider at Virios Therapeutics, Inc..
Set alerts for La Rosa Abel De and 40,000+ other insiders.